OTC Capital Partners » Cancer Drug http://otccapitalpartners.com/b Your source for creative financing Thu, 09 Feb 2012 09:00:03 +0000 en hourly 1 http://wordpress.org/?v=3.3.1 Rodman Arranges 30th PIPE for Cancer Drug Developer Cell Therapeutics http://otccapitalpartners.com/b/rodman-arranges-30th-pipe-for-cancer-drug-developer-cell-therapeutics/ http://otccapitalpartners.com/b/rodman-arranges-30th-pipe-for-cancer-drug-developer-cell-therapeutics/#comments Fri, 09 Dec 2011 18:14:08 +0000 The PIPEs Report http://otccapitalpartners.com/b/rodman-arranges-30th-pipe-for-cancer-drug-developer-cell-therapeutics/ Rodman & Renshaw is arranging the 30th PIPE financing for cancer drug developer Cell Therapeutic…
Source >>>

]]> http://otccapitalpartners.com/b/rodman-arranges-30th-pipe-for-cancer-drug-developer-cell-therapeutics/feed/ 0 Cancer Drug Maker Goes Public, Raises $55M in Reverse Merger http://otccapitalpartners.com/b/cancer-drug-maker-goes-public-raises-55m-in-reverse-merger-2/ http://otccapitalpartners.com/b/cancer-drug-maker-goes-public-raises-55m-in-reverse-merger-2/#comments Thu, 06 Oct 2011 20:06:00 +0000 admin http://otccapitalpartners.com/b/cancer-drug-maker-goes-public-raises-55m-in-reverse-merger-2/ Puma Biotechnology, a Los Angeles biotechnology company making treatments for cancer, agreed to go p…
Source >>>

]]> http://otccapitalpartners.com/b/cancer-drug-maker-goes-public-raises-55m-in-reverse-merger-2/feed/ 0 Cancer Drug Maker Goes Public, Raises $55M in Reverse Merger http://otccapitalpartners.com/b/cancer-drug-maker-goes-public-raises-55m-in-reverse-merger/ http://otccapitalpartners.com/b/cancer-drug-maker-goes-public-raises-55m-in-reverse-merger/#comments Thu, 06 Oct 2011 19:40:18 +0000 The PIPEs Report http://otccapitalpartners.com/b/cancer-drug-maker-goes-public-raises-55m-in-reverse-merger/ Puma Biotechnology, a Los Angeles biotechnology company making treatments for cancer, agreed to go p…
Source >>>

]]> http://otccapitalpartners.com/b/cancer-drug-maker-goes-public-raises-55m-in-reverse-merger/feed/ 0 Rodman Raising $12.7M in 16th PIPE for Cancer Drug Maker Genta http://otccapitalpartners.com/b/rodman-raising-12-7m-in-16th-pipe-for-cancer-drug-maker-genta/ http://otccapitalpartners.com/b/rodman-raising-12-7m-in-16th-pipe-for-cancer-drug-maker-genta/#comments Tue, 06 Sep 2011 23:50:02 +0000 The PIPEs Report http://otccapitalpartners.com/b/rodman-raising-12-7m-in-16th-pipe-for-cancer-drug-maker-genta/ Rodman & Renshaw is arranging a $12.7 million private placement of convertible debt for Genta In…
Source >>>

]]> http://otccapitalpartners.com/b/rodman-raising-12-7m-in-16th-pipe-for-cancer-drug-maker-genta/feed/ 0 Rodman Arranges $18.4M for Cancer Drug Developer Celsion http://otccapitalpartners.com/b/rodman-arranges-18-4m-for-cancer-drug-developer-celsion/ http://otccapitalpartners.com/b/rodman-arranges-18-4m-for-cancer-drug-developer-celsion/#comments Thu, 21 Jul 2011 20:40:31 +0000 The PIPEs Report http://otccapitalpartners.com/b/rodman-arranges-18-4m-for-cancer-drug-developer-celsion/ Rodman & Renshaw arranged $18.4 million in private placement financing for cancer drug developer Cel…
Source >>>

]]> http://otccapitalpartners.com/b/rodman-arranges-18-4m-for-cancer-drug-developer-celsion/feed/ 0 Venture Capitalist Duggan Among Investors of $57M in Cancer Drug Maker http://otccapitalpartners.com/b/venture-capitalist-duggan-among-investors-of-57m-in-cancer-drug-maker/ http://otccapitalpartners.com/b/venture-capitalist-duggan-among-investors-of-57m-in-cancer-drug-maker/#comments Fri, 17 Jun 2011 20:30:02 +0000 The PIPEs Report http://otccapitalpartners.com/b/venture-capitalist-duggan-among-investors-of-57m-in-cancer-drug-maker/ Venture capitalist Robert Duggan is among the investors in a $57 million registered direct offering …
Source >>>

]]> http://otccapitalpartners.com/b/venture-capitalist-duggan-among-investors-of-57m-in-cancer-drug-maker/feed/ 0 AVEO Pharma Raises $100.6M in Registered Direct http://otccapitalpartners.com/b/aveo-pharma-raises-100-6m-in-registered-direct-2/ http://otccapitalpartners.com/b/aveo-pharma-raises-100-6m-in-registered-direct-2/#comments Wed, 15 Jun 2011 22:20:06 +0000 The PIPEs Report http://otccapitalpartners.com/b/aveo-pharma-raises-100-6m-in-registered-direct-2/ Cancer drug maker AVEO Pharmaceuticals (AVEO) raised $100.6 million from the sale of 5.75 million sh…
Source >>>

]]> http://otccapitalpartners.com/b/aveo-pharma-raises-100-6m-in-registered-direct-2/feed/ 0 AVEO Pharma Raises $100.6M in Registered Direct http://otccapitalpartners.com/b/aveo-pharma-raises-100-6m-in-registered-direct/ http://otccapitalpartners.com/b/aveo-pharma-raises-100-6m-in-registered-direct/#comments Wed, 15 Jun 2011 22:20:02 +0000 The PIPEs Report http://otccapitalpartners.com/b/aveo-pharma-raises-100-6m-in-registered-direct/ Cancer drug maker AVEO Pharmaceuticals (AVEO) raised $100.6 million from the sale of 5.75 million sh…
Source >>>

]]> http://otccapitalpartners.com/b/aveo-pharma-raises-100-6m-in-registered-direct/feed/ 0 Rodman Arranging 28th PIPE for Cancer Drug Specialist Cell Therapeutics http://otccapitalpartners.com/b/rodman-arranging-28th-pipe-for-cancer-drug-specialist-cell-therapeutics/ http://otccapitalpartners.com/b/rodman-arranging-28th-pipe-for-cancer-drug-specialist-cell-therapeutics/#comments Thu, 28 Apr 2011 19:20:03 +0000 The PIPEs Report http://otccapitalpartners.com/b/rodman-arranging-28th-pipe-for-cancer-drug-specialist-cell-therapeutics/ Rodman & Renshaw is arranging a $16 million registered direct offering of convertible preferred …
Source >>>

]]> http://otccapitalpartners.com/b/rodman-arranging-28th-pipe-for-cancer-drug-specialist-cell-therapeutics/feed/ 0 Lost flu sales weigh on Roche and other pharmas in Q1 http://otccapitalpartners.com/b/lost-flu-sales-weigh-on-roche-and-other-pharmas-in-q1/ http://otccapitalpartners.com/b/lost-flu-sales-weigh-on-roche-and-other-pharmas-in-q1/#comments Mon, 11 Apr 2011 16:35:32 +0000 Reuters: Business News http://otccapitalpartners.com/b/lost-flu-sales-weigh-on-roche-and-other-pharmas-in-q1/ LONDON (Reuters) – Roche is set to kick off the Big Pharma reporting season with a fall in sales on Thursday as a strong Swiss franc, weak demand for top-selling cancer drug Avastin and lack of Tamiflu revenue take their toll.



Source >>>

]]> http://otccapitalpartners.com/b/lost-flu-sales-weigh-on-roche-and-other-pharmas-in-q1/feed/ 0